Schooler C, Spohn H E
Schizophr Bull. 1982;8(1):85-98. doi: 10.1093/schbul/8.1.85.
Recent evaluation of a 20-year-old experimental ward resocialization program for chronic schizophrenics indicates that the general level of activity, much of it social, was disruptive to the psychological functioning of patients, particularly sicker ones. Antipsychotic drugs positively affected psychological functioning and also decreased social behavior. A review of other studies indicates that we are not unique in finding that intensive socioenvironmental therapies have adverse effects on schizophrenics. Furthermore, a wide range of studies indicates that schizophrenics are prone to avoid social interaction and show a decrement in functioning as the intensity of such interactions increases. Unfortunately, although various hypotheses seem feasible, little is known about the reasons for schizophrenics' social dysfunction and little research is presently being done. Given the recent findings that neuroleptic drug treatment by itself is insufficient to keep many patients out of the hospital and that those that stay in the community show an increase in withdrawal, the development of successful treatment programs for schizophrenia may hinge upon our learning more about the nature of and reasons for the schizophrenic's social dysfunction.
最近对一项针对慢性精神分裂症患者开展了20年的实验性病房再社会化项目的评估表明,活动的总体水平,其中大部分是社交活动,对患者的心理功能具有干扰性,对病情较重的患者尤其如此。抗精神病药物对心理功能有积极影响,同时也减少了社交行为。对其他研究的综述表明,我们并非唯一发现强化社会环境疗法对精神分裂症患者有不良影响的。此外,大量研究表明,精神分裂症患者倾向于避免社交互动,并且随着这种互动强度的增加,其功能会出现下降。不幸的是,尽管各种假设似乎可行,但对于精神分裂症患者社会功能障碍的原因知之甚少,目前也几乎没有相关研究。鉴于最近的研究发现,仅使用抗精神病药物治疗不足以使许多患者避免住院,而且那些留在社区的患者出现退缩行为增多的情况,成功的精神分裂症治疗方案的开发可能取决于我们更多地了解精神分裂症患者社会功能障碍的本质和原因。